-Shanghai T&W Pharmaceutical Co., Ltd .:

Business scope: Mainly develop and produce antiviral, anticancer, cardiovascular and other APIs and advanced intermediates.

Advantages: We have flexible productivity that meets cGMP standards. The Jiangsu production base has passed on-site inspection by the US FDA.

-Shanghai T&W Trading Co., Ltd .:

Business Scope: On the one hand, we represent foreign customers in the procurement of fine chemicals in China. On the other hand, we use our many market resources to help domestic manufacturers actively explore the international market. At the same time, we also conduct incubation and investment in high-tech and enterprises in the fields of medicine, biology, and chemical industry.

Advantages:

1. Our purchasing engineers all have a solid background in chemistry, coupled with years of accumulated experience, we have a good understanding of domestic supplier systems on the one hand, and hundreds of pharmaceutical and chemical companies and R & D institutions on the other. Established a close cooperative relationship. This gives us the opportunity to become a sourcing expert for Chinese chemicals.

2. We provide customers with one-stop, integrated procurement services, from demand analysis, market research, supplier selection, on-site auditing, to contract management, quality control, logistics and document registration, etc., so as to improve customer benefits, reduce risk and costs.

3. According to customer needs, provide suitable payment terms, ranging from 30 days to 240 days.

4. In addition to higher value products, we provide customers with a free sample policy.

-Bettersyn（Shanghai）Biotech Co., Ltd:

 Business scope: custom synthesis, custom production of bulk drugs, pharmaceutical intermediates and fine chemicals.

 Advantages:

1. Abundant production experience from pilot to scale up.
2. Quick response and timely communication to ensure that the project is completed on time and on budget.
3. International standard quality management system and EHS.
4. Strict implementation of intellectual property protection regulations

-Partner Clients